Advertisement
Codiak BioSciences Inc. (CDAK)
Company Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases.
Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors.
The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; and exoVACC, a modular platform for constructing precision vaccines.
It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics S.A.S., Washington University, Ragon Institute of MGH, MIT, and Harvard.
The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
| Country | United States |
| IPO Date | Oct 14, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 102 |
| CEO | Dr. Douglas Edward Williams Ph.D. |
Advertisement
Contact Details
Address: 35 Cambridge Park Drive Cambridge, Massachusetts United States | |
| Website | https://www.codiakbio.com |
Stock Details
| Ticker Symbol | CDAK |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001659352 |
| CUSIP Number | 192010106 |
| ISIN Number | US1920101060 |
| Employer ID | 00-0000000 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Douglas Edward Williams Ph.D. | Pres, Chief Executive Officer & Director |
| Dr. Konstantin Konstantinov Ph.D. | Chief Technology Officer |
| Linda Cathavina Bain CPA | Chief Financial Officer & Treasurer |
| Yalonda Howze | Executive Vice President, Chief Legal Officer, Chief Compliance Officer & Corporation Sec. |
| Christopher J. M. Taylor | Vice President of Investor Relations & Corporation Communications |
| Dr. Benny Sorensen M.D., Ph.D. | Member of Scientific Advisory Board & Consultant |
| Dr. David J. Mauro M.D., Ph.D. | Chief Medical Officer |
| Dr. Sriram Sathyanarayanan Ph.D. | Chief Scientific Officer |
| Nicole Barna | Senior Vice President of HR |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| May 02, 2023 | 25-NSE | Filing |
| Apr 10, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Mar 30, 2023 | 4 | Filing |
| Mar 30, 2023 | 4 | Filing |
| Mar 30, 2023 | 4 | Filing |
| Mar 30, 2023 | 4 | Filing |
| Mar 30, 2023 | 4 | Filing |
| Mar 30, 2023 | 4 | Filing |
| Mar 29, 2023 | NT 10-K | Filing |